← Sotera Health Co
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|
| Net income | ($20.4m) | ($37.5m) | $117.1m | ($233.6m) | $51.4m | $44.4m | $77.9m | |
| Depreciation | $66.7m | $63.3m | $64.2m | $64.0m | $76.6m | $84.3m | $94.9m | |
| Amortization of intangible assets | $80.0m | $80.3m | $86.7m | $81.6m | $81.3m | $79.4m | $41.8m | |
| Amortization of debt issuance costs | $8.3m | $11.6m | $6.2m | $5.7m | $9.1m | $7.2m | $5.4m | |
| Deferred income taxes | ($19.0m) | ($23.4m) | ($3.7m) | ($74.0m) | $3.4m | $9.4m | $22k | |
| Share-based compensation expense | $6.9m | $11.0m | $13.9m | $21.2m | $32.2m | $36.8m | $30.9m | |
| Loss on refinancing of debt | — | — | — | $0 | $0 | $24.2m | $1.5m | |
| Accretion expense | $2.1m | $2.0m | $2.3m | $2.2m | $2.4m | $2.6m | $2.3m | |
| Unrealized foreign exchange loss (gain) | $3.3m | ($10.6m) | $788k | ($4.0m) | $6.1m | ($18.3m) | $9.5m | |
| Unrealized (gain) loss on derivatives not designated as hedging instruments | — | ($3.1m) | ($1.2m) | $3.0m | ($1.6m) | $2.2m | ($863k) | |
| Other | ($5.2m) | ($5.5m) | ($12.7m) | ($7.0m) | ($5.3m) | ($5.4m) | ($4.3m) | |
| Accounts receivable | $11.8m | $1.9m | ($15.5m) | ($12.6m) | ($21.7m) | $2.2m | $7.2m | |
| Inventories | ($282k) | $3.8m | ($20.2m) | $14.4m | ($10.0m) | ($4.8m) | ($2.4m) | |
| Other current assets | $15.3m | ($7.8m) | ($3.6m) | ($5.8m) | $4.0m | $3.6m | ($12.9m) | |
| Accounts payable | ($9.0m) | ($6.0m) | $19.8m | $1.1m | ($5.3m) | ($6.6m) | $5.2m | |
| Accrued liabilities | ($18.4m) | $3.2m | $1.6m | $20.6m | $3.5m | $7.1m | $1.9m | |
| Litigation settlement | — | — | $0 | $408.0m | ($372.7m) | ($35.0m) | $34.0m | |
| Income taxes payable / receivable, net | ($7.8m) | ($8.1m) | $10.1m | ($12.3m) | $924k | $1.5m | ($5.5m) | |
| Other liabilities | $724k | ($657k) | ($369k) | $383k | ($1.7m) | ($3.8m) | $295k | |
| Other long-term assets | ($735k) | $1.8m | ($4.4m) | ($4.6m) | ($238k) | ($6.8m) | $212k | |
| Proceeds from long-term borrowings | $3.1b | $150.0m | $0 | $200.0m | $500.0m | $2.3b | $0 | |
| Payment of revolving credit facility | — | — | $0 | $0 | ($200.0m) | $0 | $0 | |
| Payments of long-term borrowings | ($2.6b) | ($1.2b) | ($100.0m) | $0 | ($2.5m) | ($2.3b) | ($86.1m) | |
| Buyout of leased facility | — | — | — | $0 | $0 | ($6.7m) | $0 | |
| Shares withheld for employee taxes on equity awards | $0 | $0 | ($1.4m) | ($393k) | ($4.1m) | ($4.4m) | ($6.6m) | |
| Purchases of property, plant and equipment included in accounts payable | $5.2m | $14.3m | $14.5m | $16.4m | $16.7m | $10.2m | $25.3m | |
| Net cash provided by (used in) operating activities | $149.0m | $120.6m | $281.5m | $278.0m | ($147.7m) | $224.2m | $287.2m | |
| Purchases of property, plant and equipment | ($57.3m) | ($53.5m) | ($102.2m) | ($182.4m) | ($215.0m) | ($179.1m) | ($138.0m) | |
| Other investing activities | $0 | $0 | ($701k) | $32k | $69k | $74k | $2.9m | |
| Net cash used in investing activities | ($57.3m) | ($158.7m) | ($159.8m) | ($181.9m) | ($214.9m) | ($179.0m) | ($135.1m) | |
| Payments of debt issuance costs and debt discount | — | — | — | ($31k) | ($25.6m) | ($32.1m) | ($4.4m) | |
| Other financing activities | ($1.3m) | ($1.5m) | ($642k) | ($1.8m) | ($1.8m) | ($2.3m) | ($3.5m) | |
| Net cash (used in) provided by financing activities | ($126.0m) | $73.4m | ($117.3m) | $197.8m | $266.0m | ($50.6m) | ($100.5m) | |
| Effect of exchange rate changes on cash and cash equivalents | $485k | $4.1m | $44k | ($4.5m) | $2.0m | ($17.4m) | $16.1m | |
| Net increase (decrease) in cash and cash equivalents, including restricted cash | ($33.8m) | $39.4m | $4.5m | $289.4m | ($94.6m) | ($22.8m) | $67.6m | |
| Cash and cash equivalents, including restricted cash, at beginning of period | $63.0m | $102.5m | $106.9m | $396.3m | $301.7m | $278.9m | $346.5m | |
| Cash paid during the period for interest | $151.0m | $211.3m | $58.8m | $75.8m | $173.8m | $179.9m | $164.0m | |
| Cash paid during the period for income taxes, net of tax refunds received | $44.6m | $24.0m | $52.0m | $75.5m | $50.2m | $65.8m | $60.9m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.